Huan-zhong SHI. Rational and Helpless Choices: Seven Issues of 2018 ATS/STS/STR Management Guideline for the Malignant Pleural Effusion[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(6): 566-568. doi: 10.3969/j.issn.1674-9081.2018.06.015
Citation:
Huan-zhong SHI. Rational and Helpless Choices: Seven Issues of 2018 ATS/STS/STR Management Guideline for the Malignant Pleural Effusion[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(6): 566-568. doi: 10.3969/j.issn.1674-9081.2018.06.015
Huan-zhong SHI. Rational and Helpless Choices: Seven Issues of 2018 ATS/STS/STR Management Guideline for the Malignant Pleural Effusion[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(6): 566-568. doi: 10.3969/j.issn.1674-9081.2018.06.015
Citation:
Huan-zhong SHI. Rational and Helpless Choices: Seven Issues of 2018 ATS/STS/STR Management Guideline for the Malignant Pleural Effusion[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(6): 566-568. doi: 10.3969/j.issn.1674-9081.2018.06.015
Department of Respiratory and Critical Care Medicine & Beijing Institute of Respiratory Medicine, Beijing Chao-yang Hospital Affiliated to Capital Medical University, Beijing 100020, China
"Management of malignant pleural effusions (MPE)", an official clinical practice guideline approved by the American Thoracic Society, the Society of Thoracic Surgeons, and the Society of Thoracic Radiology, was published in the American Journal of Respiratory and Critical Care Medicine on October 1st, 2018. Using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach and the PICO (Population, Intervention, Comparator, and Outcomes) format, a multidisciplinary panel raised and answered seven questions on the clinical management of MPE. The relevant evidences were summarized and recommendations were developed for clinical practice. Based on the available evidence, the panel made the following recommendations:(1)ultrasound imaging should be used to guide pleural interventions in patients with known or suspected MPE; (2)therapeutic pleural interventions should not be performed in asymptomatic patients with known or suspected MPE; (3)either an indwelling pleural catheter (IPC) or chemical pleurodesis can be used in symptomatic patients with MPE and suspected expandable lung; (4)large-volume thoracentesis can be conducted to assess symptomatic response and lung expansion; (5)the use of either talc poudrage or talc slurry can be considered in patients with symptomatic MPE and expandable lung; (6)IPC should be used instead of pleurodesis in patients with nonexpandable lung or failed pleurodesis; and (7)antibiotics should be used in IPC-associated infections and there is no need to removed the catheter.
Taghizadeh N, Fortin M, Tremblay A. US hospitalizations for malignant pleural effusions:data from the 2012 National Inpatient Sample[J]. Chest, 2017, 151:845-854. doi: 10.1016/j.chest.2016.11.010
[2]
Porcel JM, Gasol A, Bielsa S, et al. Clinical features and survival of lung cancer patients with pleural effusions[J]. Respirology, 2015, 20:654-659. doi: 10.1111/resp.12496
[3]
Feller-Kopman D, Light R. Pleural disease[J]. N Engl J Med, 2018, 378:740-751. doi: 10.1056/NEJMra1403503
[4]
American Thoracic Society. Management of malignant pleural effusions[J]. Am J Respir Crit Care Med, 2000, 162:1987-2001. doi: 10.1164/ajrccm.162.5.ats8-00
[5]
Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion:British Thoracic Society Pleural Disease Guideline 2010[J]. Thorax, 2010, 65 Suppl 2:ii32-ii40. http://www.ncbi.nlm.nih.gov/pubmed/20696691
Bhatnagar R, Keenan EK, Morley AJ, et al. Outpatient talc administration by indwelling pleural catheter for malignant effusion[J]. N Engl J Med, 2018, 378:1313-1322. doi: 10.1056/NEJMoa1716883
[9]
Xia H, Wang XJ, Zhou Q, et al. Efficacy and safety of talc pleurodesis for malignant pleural effusion:a meta-analysis[J]. PLoS One, 2014, 9:e87060. doi: 10.1371/journal.pone.0087060